Seeking male and female preterm newborns who have been diagnosed with Respiratory Distress Syndrome.
The respiratory disorder caused by lack of a naturally produced substance called surfactant in the immature lung of preterm babies is called “Respiratory Distress Syndrome” (RDS). The purpose of this study is to assess how safe and effective it is to use a different method of administration of the medication used to address RDS compared to the standard method.
What we're hoping for
Evaluate the safety and effectiveness of an investigational thin catheter to administer Curosurf for preterm babies who have signs of of RDS, compared with the standard method of administration (ET Tube).
ClinicalTrials.gov Identifier: NCT02772081